ESR1 and breast cancer: The ER/PgR status is no longer sufficient to treat breast cancer patients in Ivory Coast since the human epidermal growth factor receptor 2 (Her2) overexpression analysis and the Ki67 index are required to define the molecular classification of breast cancers for better treatment strategies.